Evidence map›Paper›PMID 39359525›Full record

ArticleJournal of ophthalmic & vision research

Clinical Manifestations and Outcomes of Ocular Graft Versus Host Disease following Allogeneic Stem Cell Transplantation.

Vijay Shetty, Priyanka Kashelkar, Sachin Punatar, Suhas Haldipurkar, Abhishek Hoshing, Rasika Thakur, Prachi Sankhe, Shabnam Tanwar, Tanvi Haldipurkar, Maninder Singh Setia and 4 more

Abstract read
In one paragraph

Article in Journal of ophthalmic & vision research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Vijay ShettyLaxmi Eye Institute, Panvel, Navi Mumbai, India.
Priyanka KashelkarLaxmi Eye Institute, Panvel, Navi Mumbai, India.
Sachin PunatarStem Cell Transplant Unit, Department of Medical Oncology, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Suhas HaldipurkarLaxmi Eye Institute, Panvel, Navi Mumbai, India.
Abhishek HoshingLaxmi Eye Institute, Panvel, Navi Mumbai, India.
Rasika ThakurLaxmi Eye Institute, Panvel, Navi Mumbai, India.
Prachi SankheLaxmi Eye Institute, Panvel, Navi Mumbai, India.
Shabnam TanwarLaxmi Eye Institute, Panvel, Navi Mumbai, India.
Tanvi HaldipurkarLaxmi Eye Institute, Panvel, Navi Mumbai, India.
Maninder Singh SetiaLaxmi Eye Institute, Panvel, Navi Mumbai, India.
Anant GokarnStem Cell Transplant Unit, Department of Medical Oncology, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Lingaraj NayakStem Cell Transplant Unit, Department of Medical Oncology, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Avinash BondaStem Cell Transplant Unit, Department of Medical Oncology, ACTREC, Tata Memorial Centre, Navi Mumbai, India.
Navin KhattryStem Cell Transplant Unit, Department of Medical Oncology, ACTREC, Tata Memorial Centre, Navi Mumbai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate clinical presentation of chronic ocular graft-versus-host disease (GVHD), laterality of presentation, and longitudinal changes in patients undergoing allogeneic stem cell transplantation. Methods: This is a retrospective longitudinal analysis of 60 eyes from 30 patients who had undergone hematopoietic stem cell transplantation. Demographic characteristics, clinical history, comorbidities, and other organ involvements were taken into account for analysis. We also undertook complete evaluation of the eyes, including cornea and anterior segment, posterior segment, Schirmer test, tear break-up time, ocular surface disease index, and intraocular pressure. Results: The mean age of the patients was 34.3 Conclusion: Although the initial presentations were SPEEs, meibomitis, blepharitis, and conjunctival congestion, these inflammatory conditions were reduced over time with proper management. However, there was an increase in the proportion of patients with cataract. It is important to regularly monitor these patients in order to identify and manage the initial as well as the late ocular manifestations of chronic GVHD.

Indexed as

Anterior SegmentCorneaLongitudinal StudyOcular Graft-versus-Host DiseasePosterior Segment

Identifiers

PMID39359525
PMCPMC11443995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.